Therapeutic Asset Ratings

705 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Fludarabine Female Reproductive Organ Cancer	Masonic Cancer Center, University of Minnesota	P1	CC (41)
ft536 Female Reproductive Organ Cancer	Masonic Cancer Center, University of Minnesota	P1	CC (41)
Myopaxon Duchenne Muscular Dystrophy	Masonic Cancer Center, University of Minnesota	P1	CC (41)
TACROLIMUS Duchenne Muscular Dystrophy	Masonic Cancer Center, University of Minnesota	P1	CC (41)
Enoblituzumab Ovarian Cancer	Masonic Cancer Center, University of Minnesota	P1	C (39)
hcw9218 Neoplasm	Masonic Cancer Center, University of Minnesota	P1	C (39)
LISPRO-PH20 COMPONENT RHUPH20 Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P1	C (39)
Vic-1911 Lymphoma	Masonic Cancer Center, University of Minnesota	P1/2	C (39)
Vic-1911 Myelodysplastic Syndrome	Masonic Cancer Center, University of Minnesota	P1/2	C (39)
Enoblituzumab Cancer	Masonic Cancer Center, University of Minnesota	P1	C (37)
Enoblituzumab Fallopian Tube Cancer	Masonic Cancer Center, University of Minnesota	P1	C (37)
ft536 Fallopian Tube Cancer	Masonic Cancer Center, University of Minnesota	P1	C (37)
ft536 Glioblastoma	Masonic Cancer Center, University of Minnesota	P1	C (37)
Gtb-360 Myelodysplastic Syndrome	Masonic Cancer Center, University of Minnesota	P1	C (37)
Enoblituzumab Neoplasm	Masonic Cancer Center, University of Minnesota	P1	C (36)
ft536 Ovarian Cancer	Masonic Cancer Center, University of Minnesota	P1	C (36)
Gtb-360 Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P1	C (36)
Gtb-5550 Cancer	Masonic Cancer Center, University of Minnesota	P1	C (36)
Gtb-5550 Neoplasm	Masonic Cancer Center, University of Minnesota	P1	C (36)
SIMVASTATIN Lymphoma	Masonic Cancer Center, University of Minnesota	Early P1	C (34)
92.3% TO NMT 93.8% ETHANOL BY WEIGHT IN WATER Fanconi Anemia	Masonic Cancer Center, University of Minnesota	N/A	D (30)
92.3% TO NMT 93.8% ETHANOL BY WEIGHT IN WATER Oral Cavity Carcinoma	Masonic Cancer Center, University of Minnesota	N/A	D (30)
Busulphan MHC Class II Deficiency	Masonic Cancer Center, University of Minnesota	N/A	D (30)
Busulphan Hyper-IgM Syndrome Type 1	Masonic Cancer Center, University of Minnesota	N/A	D (30)
Busulphan Chediak-Higashi Syndrome	Masonic Cancer Center, University of Minnesota	N/A	D (30)

Showing 601 to 625 of 705 assets

PreviousPage 25 of 29Next